Kits Eyecare Ltd.

Kits Eyecare Ltd.

17.24
CAD
+0.15
(+0.88%)
0.16EPS
81.96P/E
475.60MMarket Cap
Nov 11Next Earn
Kits Eyecare Ltd.
NEO:KITS
(Cboe Canada)

Recent

price

17.24

P/E

ratio

81.96

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
CAD
- -
1.19
2.43
2.74
2.93
3.84
5.04
6.32
6.73
Revenue per Share
- -
- -
-0.21
-0.49
-0.15
-0.07
0.1
0.1
0.17
Basic EPS, GAAP
- -
0.1
0.13
-0.77
0.14
0.06
0.31
0.35
0.36
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.2
-0.02
1.76
1.72
1.64
1.83
1.93
2.14
Book Value per Share
- -
-1.25
-1.39
0.45
0.38
0.39
0.49
0.68
0.91
Tangible Book Value per Share
31
31
31
30
31
31
32
32
33
Basic Weighted Avg Shares
- -
37
75
82
92
121
159
202
222
Sales/Revenue/Turnover
- -
5.47
-0.3
-21.55
-7.31
-1.19
1.73
4.08
3.84
Operating Margin (%)
- -
1
2
3
4
3
3
2
2
Depreciation Expense
- -
- -
-7
-15
-5
-2
3
3
6
Net Income, GAAP
- -
41.11
- -
- -
- -
- -
29.99
38.38
31.87
Effective Tax Rate (%)
- -
0.14
-8.75
-17.74
-4.97
-1.84
1.96
1.54
2.53
Profit Margin (%)
- -
-23
-24
19
13
9
6
15
25
Working Capital
- -
1
1
19
16
12
6
5
4
LT Debt
- -
6
-1
55
54
51
58
62
73
Total Equity
- -
7.81
- -
- -
- -
- -
5.5
5.34
9.33
Return on Invested Capital (%)
- -
7.62
- -
- -
- -
- -
5.76
4.74
8.67
Return on Capital (%)
- -
1.71
- -
- -
-8.39
-4.21
5.7
5.17
8.54
Return on Common Equity (%)

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
5
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
34
34
Market Capitalization
583
508
476

Working Capital

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
61
56
57
Cash, Cash Equivalents & STI
34
22
27
Accounts Receivable, Net
2
5
3
Inventories
24
27
25
Total Current Liabilities
45
33
32
Payables & Accruals
27
24
24
ST Debt
11
1
1
Deferred Revenue
7
7
7

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-1,929.42%
7.64%
Free Cash Flow
- -
-81.98%
14.62%
Net Income, GAAP
- -
-47.81%
-0.19%
Sales/Revenue/Turnover
- -
22.31%
27.06%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
35
38
42
45
159
2025
47
50
52
54
202
2026
57
58
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.01
- -
0.09
0.1
2025
0.05
-0.02
0.06
0.01
0.1
2026
0.06
0.04
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Kits Eyecare Ltd. (TSX: KITS) operates as a vertically integrated online retailer of eyeglasses and vision care products in Canada. The company manufactures, markets, and sells prescription eyeglasses, non-prescription sunglasses, contact lenses, and related vision care accessories through its e-commerce platform and physical retail locations; it offers a portfolio of owned and licensed brands including its flagship Kits brand, along with private-label options and designer collaborations. Kits Eyecare provides comprehensive services such as virtual try-on technology, in-house optical labs for custom lens production, same-day prescription fulfillment, and eye exam partnerships with licensed optometrists.[ from prior context] Founded in 2018 and headquartered in Vancouver, British Columbia, the company serves the Canadian consumer market with a focus on affordable, high-quality vision care solutions for adults and children. Its operations span online sales nationwide and brick-and-mortar stores in major urban centers across British Columbia, Alberta, and Ontario. Kits Eyecare targets budget-conscious consumers seeking convenience over traditional optical retail, competing in the digital health and e-commerce eyewear segment.[ from prior context] In recent developments, Kits Eyecare completed its initial public offering on the Toronto Stock Exchange in May 2024, raising approximately C$65 million to fuel expansion; the company launched new physical retail formats and expanded its lab capacity in 2024-2025 to support growing demand. It announced strategic partnerships with major lens manufacturers for advanced progressive and blue-light blocking technologies in late 2024. No major acquisitions, rebrands, or funding rounds have been reported in 2025 as of December.

Company News

  • Cedar Grove Capital Q3 2026 Portfolio Update

  • Kits Eyecare Q2 Earnings Call Highlights

  • Kits Eyecare Ltd. (KITS:CA) Q1 2026 Earnings Call Transcript

  • Short Interest in Kits Eyecare Ltd. (OTCMKTS:KTYCF) Rises By 54.6%

  • Kits Eyecare: A Buying Opportunity After The Recent Sell-Off

  • Kits Eyecare Ltd. (KITS:CA) Q4 2025 Earnings Call Transcript

  • Kits Eyecare Ltd. (KITS:CA) Q3 2025 Earnings Call Transcript